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Abstract
Background: Normal cell cycle progression requires the precise activation and inactivation of cyclindependent protein kinases (CDKs), which consist of a CDK and a cyclin subunit. A novel cell cycle
regulator called Speedy/Ringo shows no sequence similarity to cyclins, yet can directly bind to and activate
CDKs. Speedy/Ringo proteins, which bind to and activate Cdc2 and Cdk2 in vitro, are required for the G2
to M transition during Xenopus oocyte maturation and for normal S-phase entry in cultured human cells.
Results: We have characterized the substrate specificity and enzymatic activity of human Cdk2-Speedy/
Ringo A2 in order to gain insights into the possible functions of this complex. In contrast to Cdk2-cyclin
A, which has a well-defined consensus target site ((S/T)PX(K/R)) that strongly favors substrates containing
a lysine at the +3 position of substrates, Cdk2-Speedy/Ringo A2 displayed a broad substrate specificity at
this position. Consequently, Cdk2-Ringo/Speedy A2 phosphorylated optimal Cdk2 substrates such as
histone H1 and a KSPRK peptide poorly, only ~0.08% as well as Cdk2-cyclin A, but non-canonical Cdk2
substrates such as a KSPRY peptide relatively well, with an efficiency of ~80% compared to Cdk2-cyclin A.
Cdk2-Speedy/Ringo A2 also phosphorylated authentic Cdk2 substrates, such as Cdc25 proteins, which
contain non-canonical CDK phosphorylation sites, nearly as well as Cdk2-cyclin A. Phosphopeptide
mapping indicated that Cdk2-Speedy/Ringo A2 and Cdk2-cyclin A phosphorylate distinct subsets of sites
on Cdc25 proteins. Thus, the low activity that Cdk2-Speedy/Ringo A2 displays when assayed on
conventional Cdk2 substrates may significantly underestimate the potential physiological importance of
Cdk2-Speedy/Ringo A2 in phosphorylating key subsets of Cdk2 substrates. Unlike Cdk2-cyclin A, whose
activity depends strongly on activating phosphorylation of Cdk2 on Thr-160, neither the overall catalytic
activity nor the substrate recognition by Cdk2-Speedy/Ringo A2 was significantly affected by this
phosphorylation. Furthermore, Cdk2-Speedy/Ringo A2 was not a suitable substrate for metazoan CAK
(which phosphorylates Cdk2 at Thr-160), supporting the notion that Speedy/Ringo A2 activates Cdk2 in
a CAK-independent manner.
Conclusion: There are major differences in substrate preferences between CDK-Speedy/Ringo A2 and
Cdk2-cyclin complexes. These differences may accommodate the CAK-independent activation of Cdk2 by
Speedy/Ringo A2 and they raise the possibility that CDK-Speedy/Ringo A2 complexes could phosphorylate
and regulate a subset of non-canonical CDK substrates, such as Cdc25 protein phosphatases, to control
cell cycle progression.
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Background
Eukaryotic cell cycle progression is under the control of
cyclin-dependent kinases (CDKs). In higher eukaryotic
cells, Cdc2, Cdk2, Cdk4, and Cdk6 control cell cycle progression. Their activities are regulated through a variety of
mechanisms, including association with regulatory subunits (cyclins, inhibitors, and assembly factors), subcellular
localization, transcriptional regulation, selective proteolysis, and reversible protein phosphorylation (reviewed in
[1-7]).
Binding of a cyclin to a CDK is a crucial step in its activation and leads to its phosphorylation on multiple sites [58]. Activating phosphorylation within the activation segment (also called the T-loop) on a conserved threonine
residue (Thr-160 in Cdk2) is required for CDK activities in
vitro and in vivo [9-16] and is carried out by the Cdk-activating kinase (CAK), which is composed of Cdk7, cyclin
H, and Mat1 in most eukaryotes. Inhibitory phosphorylations occur on sites equivalent to Thr-14 and Tyr-15 in
human Cdc2 or Cdk2 and are carried out by Wee1-like
protein kinases (Wee1 and Myt1), and removed by members of the Cdc25 phosphatase family (reviewed in [6,7]).
In addition to activating CDKs, cyclins also contribute to
their substrate specificities [17-20] and to their subcellular
localizations [21]. A general consensus sequence for efficient phosphorylation by Cdc2 and Cdk2 is (K/R)(S/
T)PX(K/R) [22-24], in which a basic residue at the +3 position three amino acids C-terminal to the phosphorylated
Ser or Thr is particularly important.
In addition to their activation by cyclins, CDKs can be
activated by a novel cell cycle regulator called Speedy or
Ringo (Rapid inducer of G2/M progression in oocytes),
despite the lack of any primary sequence homology
between cyclins and Speedy/Ringo proteins [25-28].
Speedy/Ringo proteins were initially described in Xenopus
based on their ability to promote the G2 to M transition
during oocyte maturation [25,26]. Xenopus Speedy/Ringo
bound to and activated Cdc2 and Cdk2 in vitro [26,27]. A
human Speedy/Ringo homologue (Spy1) is essential for
S-phase entry in cultured somatic cells in a Cdk2-dependent manner: overexpression of human Spy1 accelerated Sphase entry and cell proliferation, and its inhibition by
RNAi caused a cell cycle delay at G1/S [28]. These biological functions of Speedy/Ringo proteins were dependent
on CDK activity since kinase-inactive forms of Cdc2 and
Cdk2 abolished the effects of Spy1 on cell cycle transitions
[26,28]. Interestingly, unlike CDK-cyclin complexes
whose phosphorylation on the activating site is essential
for activity, Speedy/Ringo proteins can activate Cdc2 and
Cdk2 in vitro in the absence of activating phosphorylation
of the CDK [27]. Thus, Xenopus Speedy/Ringo could activate both wild type Cdk2 and Cdk2T160A equally well and
preincubation of Cdk2 with budding yeast CAK (Cak1p)

http://www.biomedcentral.com/1471-2091/6/19

had no effect on its kinase activity toward substrates such
as histone H1 [27]. Cdk2-Speedy/Ringo complexes are
also resistant to the inhibitory effects of p21Waf1/Cip1 and
Wee1 [27]. Paradoxically, although this ability of CDKSpeedy/Ringo complexes to bypass many forms of regulation imposed on CDK-cyclin complexes might suggest
that CDK-Speedy/Ringo complexes would be highly
active, only very low enzymatic activity toward conventional substrates is associated with CDK-Speedy/Ringo
complexes isolated from cells (unpublished data).
The importance of Speedy/Ringo proteins for cell cycle
progression combined with the low protein kinase activity
of CDK-Speedy/Ringo complexes toward conventional
substrates raised the possibility that there might be major
biochemical differences between CDK-Speedy/Ringo
complexes and CDK-cyclin complexes. These differences
might explain how CDK-Speedy/Ringo complexes recognize their substrates and promote cell cycle progression.
Major differences are to be expected since the activating
phosphorylation that is dispensable for Cdk2-Speedy/
Ringo activity plays a key role in substrate recognition by
Cdk2-cyclin complexes [29,30]. Activating phosphorylation also enhances substrate binding by CDK-cyclin complexes [30]. The crystal structure of Cdk2-cyclin A with an
optimal peptide substrate showed that the activating
phosphate forms a hydrogen bond with the side-chain of
the lysine at the +3 position of the substrate [31], providing insight into how the activating phosphate participates
in substrate recognition. Although Cdk5 can be activated
by p35/p25 (cyclin subunit of Cdk5) without activating
phosphorylation, a glutamic acid side-chain in p35/p25
mimics the activating phosphate and interacts with a basic
residue at the +3 position of the substrate [32]. It will be
interesting to know how CDK-Speedy/Ringo complexes
recognize substrates efficiently and how an apparently
low level of CDK-Speedy/Ringo activity can have profound effects on cell cycle progression. A detailed biochemical understanding of CDK-Speedy/Ringo activity
should help us to understand the biological functions of
Speedy/Ringo proteins during cell cycle transitions.
In this study, we explored the biochemical properties of
human Cdk2-Speedy/Ringo A2. We found that neither its
overall catalytic activity nor its substrate recognition
required the activating phosphorylation of Cdk2. In fact,
Cdk2-Speedy/Ringo A2 was a poor substrate for phosphorylation by metazoan CAK. Cdk2-Speedy/Ringo A2 tolerated almost any amino acid residue at the +3 position of
substrates, which is strikingly different from the rigid
requirement of Cdk2-cyclin A and Cdk2-cyclin E for a
basic residue (and, in particular, for a lysine) at the +3
position. Although Cdk2-Speedy/Ringo A2 phosphorylated canonical Cdk2-cyclin A substrates such as histone
H1 and a KSPRK peptide quite poorly, it phosphorylated
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non-canonical CDK-cyclin substrates, including Cdc25
protein phosphatases, nearly as well as Cdk2-cyclin A.
These observations raise the possibility that Cdk2-Speedy/
Ringo could phosphorylate and regulate a subset of noncanonical CDK substrates, such as Cdc25 protein
phosphatases.

Results
Characterization of purified proteins
We initiated our work by purifying and characterizing the
Cdk2, cyclin A, and Speedy/Ringo A2 proteins that would
be used throughout these studies. Unphosphorylated
GST-Cdk2 ([unP]Cdk2) was expressed in E. coli and purified via its GST tag. To produce Thr160-phosphorylated
Cdk2 ([pT160]Cdk2), we used a previously described
Cdk2-Cak1p co-expression system [31,33] that can produce essentially fully phosphorylated Cdk2 [31]. As previously reported [29,33], [pT160]Cdk2 by itself displays a
low but detectable histone H1 kinase activity (Fig. 1A–B).
Cyclin A stimulated the histone H1 kinase activity of
[pT160]Cdk2 (solid circle) about 50-fold. The activation
of [pT160]Cdk2 by cyclin A plateaued when the ratio of
Cdk2 to cyclin A was about 1:1. In contrast to
[pT160]Cdk2, the histone H1 kinase activity of
[unP]Cdk2 (open squares) remained very low, even at
high cyclin A concentrations, confirming the importance
of the activating phosphorylation of Cdk2 on Thr-160
(Fig. 1A).

We next determined the histone H1 kinase activities of
[unP]Cdk2 and [pT160]Cdk2 after incubation with GSTSpeedy/Ringo A2, which was expressed and purified from
E. coli. We have found that the previously reported mammalian Speedy/Ringo protein, Spy1, is expressed as two
closely related proteins resulting from alternative splicing
[34]. These two proteins, which we term Speedy/Ringo A1
and A2, differ only at their extreme C-termini and appear
to be indistinguishable in all functional respects. Spy1
corresponds to Speedy/Ringo A1. As shown in Fig. 1B,
GST-Speedy/Ringo A2 activated [unP]Cdk2 (open
squares) and [pT160]Cdk2 (solid circles) equally well,
indicating that Speedy/Ringo A2 can bind to and activate
Cdk2 without regard to its activating phosphorylation.
Cdk2 activity plateaued at a GST-Speedy/Ringo A2 to GSTCdk2 ratio of at least 4:1. We suspect that an excess of
GST-Speedy/Ringo A2 over GST-Cdk2 was required
because much of the GST-Speedy/Ringo A2 protein aggregates, as we have observed by gel-filtration chromatography (data not shown), thereby reducing the effective
concentration of active Speedy/Ringo A2.
As an alternative way to produce functional Cdk2-Speedy/
Ringo A2 complexes, we also developed a coexpression
system in which a C-terminally hexahistidine-tagged form
of Speedy/Ringo A2 was coexpressed with untagged Cdk2
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in E. coli. [unP]Cdk2-Speedy/Ringo A2-his6 (K2A2coexp)
was purified on a metal affinity column and by gel filtration chromatography. Fractions were resolved by 10%
SDS-PAGE and transferred to a PVDF membrane. Total
proteins were detected by staining with Coomassie Brilliant Blue R-250 (Fig. 1C top panel) and Cdk2 was detected
by immunoblotting with anti-Cdk2 antibodies (Fig.
1C lower panel). Speedy/Ringo A2-his6, which migrated as
a 42 kDa protein on 10% SDS-PAGE, co-eluted with Cdk2
from the gel filtration column. The apparent MW for the
peak fractions (fractions 14–15) was ~80 kDa, close to the
combined molecular weights of monomeric Cdk2 (33
kDa) and Speedy/Ringo A2-his6 (42 kDa). The diffuse
appearance of Speedy/Ringo A2 is probably due to phosphorylation of Speedy/Ringo A2 by Cdk2 (data not
shown). The ratio of Cdk2 to Speedy/Ringo A2-his6
appears to be close to 1:1 in fractions 14 and 15, suggesting that one molecule of Speedy/Ringo A2 binds one molecule of Cdk2. K2A2coexp displayed very similar protein
kinase activity to in vitro-assembled Cdk2-Speedy/Ringo
A2 complexes (see below), suggesting that both types of
complexes may be fully active. Note that because of the
coexpression of Cdk2 and Speedy/Ringo A2, and the poor
phosphorylation of Cdk2 bound to Speedy/Ringo A2 by
both metazoan CAK (Cdk7/cyclinH/Mat1) and budding
yeast Cak1p (see below), we could only produce the
unphosphorylated form of K2A2coexp. This [unP]Cdk2Speedy/Ringo A2 heterodimer was used as a control
throughout these studies.
We measured the ATPase activities of Cdk2-cyclin A and
Cdk2-Speedy/Ringo A2 to assess the relative fractions of
functional complexes. We reasoned that ATPase activities
would be less subject to substrate specificity effects conferred by cyclin A or Speedy/Ringo A2 than protein kinase
assays. The ATPase activity of monomeric [unP]Cdk2 is
low; both activating phosphorylation and cyclin-binding
increase the turnover of ATP by 20–25 fold [29,30]. Therefore, ATPase activity should be a reasonable indicator for
the adoption of the catalytically active conformation of
Cdk2 in Cdk2-Speedy/Ringo A2 complexes. We determined the ATPase activities of [pT160]Cdk2-cyclin A and
K2A2coexp. A time course experiment (Fig. 1D) showed
that the rate of ATP hydrolysis remained linear during the
assay. The relative ATPase activities of [pT160]Cdk2-cyclin A and K2A2coexp were calculated from the slopes in Fig.
1D and are shown in Fig. 1E. The ATPase activity of
K2A2coexp was slightly higher than that of [pT160]Cdk2cyclin A, indicating that Cdk2 in K2A2coexp is as active as
that in [pT160]Cdk2-cyclin A. We should emphasize that
in vitro-assembled [unP]Cdk2-Speedy/Ringo A2 and
K2A2coexp displayed very similar activities and substrate
specificities (see below, and data not shown). Thus, it
appears that in vitro-assembled Cdk2-Speedy/Ringo A2
complexes are fully active and it is reasonable to assume
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Figure 1
Characterization
of [unP]Cdk2, [pT160]Cdk2, Speedy/Ringo A2, and K2A2coexp
Characterization of [unP]Cdk2, [pT160]Cdk2, Speedy/Ringo A2, and K2A2coexp. (A) Activation of [unP]Cdk2 and
[pT160]Cdk2 by cyclin A. 0.05 µg of [unP]Cdk2 or [pT160]Cdk2 was preincubated with the indicated amounts of cyclin A
prior to determination of its histone H1 kinase activity. (B) Activation of [unP]Cdk2 and [pT160]Cdk2 by Speedy/Ringo A2. 0.5
µg of [unP]Cdk2 or [pT160]Cdk2 was preincubated with the indicated amounts of GST-Speedy/Ringo A2 prior to determination of its histone H1 kinase activity. (C) Gel filtration analysis of K2A2coexp. Cdk2 and Speedy/Ringo A2-His6 were coexpressed in E. coli and purified on a metal affinity column. The purified K2A2coexp was loaded on a Superdex-200 column; one-ml
fractions were collected. Proteins from 20 µl of the input (lane L) or from 40 µl of fractions 9–21 were resolved by SDS-PAGE,
transferred to a PVDF membrane, and detected with a Cdk2-specific antibody (lower panel), or by staining with Coomassie Brilliant Blue R-250 (upper panel). (D) Time course of ATPase activity of [pT160]Cdk2-cyclin A and K2A2coexp. 16.7 µM of
[pT160]Cdk2-cyclin A or K2A2coexp was incubated with [γ-32P]ATP for the indicated times. Samples were chromatographed to
resolve 32Pi from [γ-32P]ATP. The rate of ATP hydrolysis was quantitated by phosphorimaging analysis. (E) The relative ATPase
activities of [pT160]Cdk2-cyclin A and K2A2coexp were calculated from the slopes in panel D. The ATPase activity of
[pT160]Cdk2-cyclin A was set to 100%.
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Figure
Effects
positions
by
Cdk2-cyclin
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alanine
a KSPRK
A substitutions
and substrate
Cdk2-Speedy/Ringo
atoneach
relative
of the
A2
phosphorylation
three charged
Effects of alanine substitutions at each of the three
charged positions in a KSPRK substrate on relative
phosphorylation by Cdk2-cyclin A and Cdk2-Speedy/
Ringo A2. The phosphorylation efficiencies of the indicated
GST peptides by K2A2coexp, [unP]Cdk2-Speedy/Ringo A2,
[pT160]Cdk2-Speedy/Ringo A2, and [pT160]Cdk2-cyclin A
were compared. Assays were performed at substrate concentrations of 50 µM. All values are relative to the phosphorylation of the wild type (KSPRK) substrate by the same
enzyme. Values represent the means ± S.E. from three separate experiments.
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Substrate specificity of Cdk2-Speedy/Ringo A2
We used a systematic panel of CDK substrates to investigate the substrate specificity of Cdk2-Speedy/Ringo A2
complexes. These substrates contained a pentapeptide of
the form XSPXX (where X indicates any amino acid) fused
to the C-terminus of GST [24]. Substrates were purified as
GST-fusion proteins from E. coli. The optimal substrates
for [pT161]Cdc2-cyclin B and [pT160]Cdk2-cyclin A have
been identified as (K/R)(S/T)PX(K/R). Substitutions of
the basic residue at the +3 position (with respect to the
phosphorylation site) had the greatest effects on phosphorylation efficiencies, both by Cdc2 and by Cdk2 [24].
Thus, KSPRK is considered the "wild-type" substrate in
these studies. We determined which position was most
important for phosphorylation by Cdk2-Speedy/Ringo A2
using alanine substitution substrates in which the charged
residues at -1, +2, and +3 were individually replaced with
alanine. We compared the abilities of these substrates to
be phosphorylated by Cdk2-Speedy/Ringo A2 (assembled
in vitro), K2A2coexp, [pT160]Cdk2-Speedy/Ringo A2, and
[pT160]Cdk2-cyclin A (Fig. 2). (Note that we are comparing relative substrate preferences and not absolute phosphorylation efficiencies, which vary greatly between Cdk2
bound to cyclin A and to Speedy/Ringo A2 (see below and

Table 1).) For all of these enzymes, replacement of the
lysine at the -1 position (ASPRK) had no effect on phosphorylation efficiency, substitution at the +2 position
(KSPAK) had a modest effect, and substitution at the +3
position (KSPRA) produced the severest effects (Fig. 2).
Cdk2-cyclin A was much more sensitive to the +2 and +3
substitutions than any of the forms of Cdk2-Speedy/
Ringo A2. Similar effects were observed using K2A2coexp
and [unP]Cdk2-Speedy/Ringo A2, suggesting that the different ways in which these complexes were produced had
little effect on their resulting substrate specificities. Phosphorylation of Cdk2 in Cdk2-Speedy/Ringo A2 complexes had virtually no effect on substrate specificity,
which was surprising given the role of this phosphate in
recognition of the +3 position of substrate by Cdk2-cyclin
A [30,31]. Nevertheless, the +3 position was the most
important position for both [unP]Cdk2-Speedy/Ringo A2
and [pT160]Cdk2-Speedy/Ringo A2, just as it is for
[pT160]Cdk2-cyclin A.
We next evaluated the substrate specificity of Cdk2Speedy/Ringo A2 at the +3 position in more detail using a
panel of GST-KSPRX substrates [24]. We first compared
the substrate specificity of [unP]Cdk2-Speedy/Ringo A2
with that of [unP]Cdk2-cyclin A, allowing us to compare
the effects of the binding partner, separate from effects
due to the Cdk2 phosphorylation state. The relative specificities of [unP]Cdk2-Speedy/Ringo A2 and [unP]Cdk2cyclin A were determined at a substrate concentration of
50 µM, which is well below the KM value of Cdk2-Speedy/
Ringo A2 and [pT160]Cdk2-cyclin A (see below and [24])
for these substrates, and thus within the linear range of the
assay. We also compared the abilities of these kinases to
phosphorylate histone H1 (5 µM). The phosphorylation
of the "wild-type" substrate (GST-KSPRK) was defined as
100%. Although [unP]Cdk2-cyclin A was less active than
fully activated [pT160]Cdk2-cyclin A, [unP]Cdk2-cyclin A
still preferred lysine and arginine residues at the +3 position (Fig. 3A), consistent with a previous report indicating
that [unP]Cdk2-cyclin A was only moderately defective in
substrate binding [29]. In striking contrast to [unP]Cdk2cyclin A, [unP]Cdk2-Speedy/Ringo A2 tolerated nearly all
amino acid substitutions at the +3 position (Fig. 3A). The
best substrates for [unP]Cdk2-Speedy/Ringo A2 contained tyrosine (Y) at 473 ± 82%, arginine (R) at 325 ±
74%, and tryptophan (W) at 293 ± 56%. More than half
of the amino acid substitutions at the +3 position produced better substrates than lysine. In fact, 17 out of the
20 substrates were phosphorylated at least 50% as
efficiently as KSPRK; only alanine, asparagine, and
glutamine yielded poor substrates. In contrast,
[pT160]Cdk2-cyclin A was unable to phosphorylate any
substitution substrate more than 5% as efficiently as
KSPRK, and most substitutions produced substrates
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Table 1: Comparison of the relative phosphorylation efficiencies of the indicated substrates by [pT160]Cdk2-cyclin A, [unP]Cdk2-Speedy/
Ringo A2, [pT160]Cdk2-Speedy/Ringo A2, and coexpressed [unP]Cdk2-Speedy/Ringo A2 (K2A2coexp). Values represent the means from
three independent experiments.

Enzyme complex

[pT160]Cdk2-cyclin A
[unP]Cdk2- Speedy/Ringo A2
[pT160]Cdk2- Speedy/Ringo A2
K2A2coexp

Histone H1 (5 µM)

1983
1.68
2.05
1.55

whose phosphorylation was undetectable (< 0.01% of
KSPRK).
We next compared the sensitivities of in vitro-assembled
[unP]Cdk2-Speedy/Ringo A2 and K2A2coexp to substitutions at the +3 position to test whether the route of formation of these complexes affected their substrate
utilization. As shown in Fig. 3B, in vitro-assembled
[unP]Cdk2-Speedy/Ringo A2 and K2A2coexp exhibited
almost identical phosphorylation efficiency profiles for
the tested substrates, including histone H1. Except for the
KSPRK and KSPRT substrates, K2A2coexp phosphorylated
all substrates slightly less efficiently than in vitro-assembled [unP]Cdk2-Speedy/Ringo A2, possibly due to its
slightly higher enzymatic activity toward KSPRK (Table I),
which was defined as 100%. Overall, the differences in
substrate specificity and enzymatic activity between the in
vitro-assembled complexes and K2A2coexp were marginal.
Both complexes could accept any amino acid side chain
except aspartate and glutamate at the +3 position.
We then determined the effect of Thr-160 phosphorylation on the substrate specificity of [pT160]Cdk2-Speedy/
Ringo A2. The optimal substrates at the +3 position were
arginine (R) at 250 ± 19%, histidine (H) at 107 ± 6%, and
lysine (K) at 100%. Phosphorylation of KSPRW and
KSPRY were reduced from the very high levels exhibited
by [unP]Cdk2-Speedy/Ringo A2 to levels more typical of
other amino acid substitutions. Overall, Thr-160
phosphorylation modulated the substrate specificity of
Cdk2-Speedy/Ringo A2 but did not transform it into a
dramatically different pattern (Fig. 3B).
To determine the absolute (rather than relative) activities
of Cdk2-cyclin A and Cdk2-Speedy/Ringo A2, we compared the abilities of [pT160]Cdk2-cyclin A and Cdk2Speedy/Ringo A2 to phosphorylate several substrates,
including histone H1, KSPRK, KSPRR, and KSPRY (Table
I). For Cdk2-cyclin A, histone H1 and KSPRK are the best
substrates, although KSPRR also fits the consensus substrate sequence, and KSPRY is an unfavorable substrate
[24]. Cdk2-Speedy/Ringo A2 phosphorylated all four substrates with similar efficiencies (Table 1). [unP]Speedy/

KSPRK (50 µM)

KSPRR (50 µM)

(pmol phosphate·min-1·µg-1 Cdk2)
1062
90
0.83
2.55
1.02
3.13
1.40
5.5

KSPRY (50 µM)

3.3
2.43
0.68
3.15

Ringo A2, [pT160]Cdk2-Speedy/Ringo A2, and K2A2coexp
phosphorylated the optimal Cdk2-cyclin A substrates histone H1 and KSPRK only about 0.1% as efficiently as
[pT160]Cdk2-cyclin A (Table 1). In fact, the Cdk2Speedy/Ringo A2 complexes were only about 6-fold more
active toward histone H1 than monomeric [pT160]Cdk2
(Fig. 1B). The differences between Cdk2-cyclin A and
Cdk2-Speedy/Ringo A2 decreased dramatically when
activity was measured toward poorer Cdk2-cyclin A substrates. For instance, K2A2coexp phosphorylated KSPRR 6%
as efficiently as [pT160]Cdk2-cyclin A and it phosphorylated KSPRY 95% as efficiently as [pT160]Cdk2-cyclin A
(Table I). Thus, the relative activities of Cdk2 bound to
cyclin A or to Speedy/Ringo A2 depend critically on the
substrate used.
To understand why Cdk2-Speedy/Ringo A2 was much less
active than [pT160]Cdk2-cyclin A toward certain substrates, we tried to assess the KM and catalytic activity
(Vmax) of Cdk2-Speedy/Ringo A2. We chose several substrates including KSPRK, KSPRR, KSPRY, and histone H1
for this analysis. Phosphorylation of these substrates by
[unP]Cdk2-Speedy/Ringo A2 and [pT160]Cdk2-Speedy/
Ringo A2 was carried out over a wide range of substrate
concentrations. The maximal concentrations were 250 µM
for histone H1 and 1000 µM for the GST-peptide substrates. The phosphorylation of histone H1, KSPRY, and
KSPRK by [unP]Cdk2-Speedy/Ringo A2 increased linearly
up to the maximum concentration of each substrate (Fig.
4A). Interestingly, the phosphorylation of the KSPRR substrate plateaued at high substrate concentrations (open
squares in Fig. 4A). We observed a similar phosphorylation efficiency-concentration relationship using K2A2coexp
(data not shown), suggesting that KSPRR is a good substrate for [unP]Cdk2-Speedy/Ringo A2. The phosphorylation of KSPRY (open circles) continued to increase
linearly even at substrate concentrations at which the
phosphorylation of KSPRR had plateaued, indicating that
[unP]Cdk2-Speedy/Ringo A2 might have a stronger
affinity for the KSPRR peptide but that it can perform the
chemical steps of catalysis more efficiently on KSPRY. We
also determined the utilization of KSPRK, KSPRR, KSPRY,
and histone H1 by [pT160]Cdk2-Speedy/Ringo A2 over
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coexp, andat[pT160]Cdk2-cyclin
Figure
Effects
[unP]Cdk2-cyclin
of3 amino acid
A, K2A2
substitutions
the +3 position of KSPRK
A
on substrate utilization by [unP]Cdk2-Speedy/Ringo A2,
Effects of amino acid substitutions at the +3 position of KSPRK on substrate utilization by [unP]Cdk2-Speedy/
Ringo A2, [unP]Cdk2-cyclin A, K2A2coexp, and [pT160]Cdk2-cyclin A. (A) Comparison of the substrate specificity of
[unP]Cdk2-Speedy/Ringo A2 (open bars) and [unP]Cdk2-cyclin A (solid bars). Assays were performed at substrate concentrations of 50 µM. All phosphorylation efficiencies are relative to the phosphorylation of the KSPRK substrate by the same
enzyme. Values represent the means ± S.E. from three separate experiments. (B) Comparison of the substrate specificities of
[unP]Cdk2-Speedy/Ringo A2, K2A2coexp, and [pT160]Cdk2-Speedy/Ringo A2. Assays were performed at substrate concentrations of 50 µM. All phosphorylation efficiencies are relative to the phosphorylation of the KSPRK substrate by the same
enzyme. Values represent the means ± S.E. from three separate experiments. Single letters indicate the amino acid at the +3
position of KSPRK. H1, histone H1.
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the same range of substrate concentrations. The phosphorylation of these four substrates increased linearly
throughout the concentration range (Fig. 4B).
Surprisingly, the phosphorylation of KSPRR by
[pT160]Cdk2-Speedy/Ringo A2 increased linearly
throughout the concentration range, suggesting that activating phosphorylation actually decreased the affinity of
Cdk2-Speedy/Ringo A2 for KSPRR. These results differ significantly from those obtained using Cdk2-cyclin A,
which has a KM for phosphorylation of histone H1 of 0.8
µM [29], and for phosphorylation of KSPRK of 150 µM
[24]. Thus, it appears that weak substrate binding contributed, at least partially, to the low enzymatic activity of
Cdk2-Speedy/Ringo A2 toward these substrates.
Phosphorylation of Cdc25 proteins
The above results indicate that Cdk2-Speedy/Ringo A2
complexes phosphorylate CDK substrates with canonical
motifs (S/T)PX(K/R) poorly compared to Cdk2-cyclin A,
but that they can phosphorylate non-canonical CDK substrates relatively well. These findings suggested that Cdk2Speedy/Ringo A2 might efficiently phosphorylate some
physiological Cdk2 substrates containing non-canonical
motifs. We reasoned that Cdc25 proteins might be such
substrates. Autoamplification of Cdc2 activity at the G2/M
transition was proposed more than a decade ago [8]. In
this model, Cdc25 protein phosphatases activate Cdc2cyclin B complexes by removing inhibitory phosphates
from Cdc2. In turn, active Cdc2-cyclin B phosphorylates
and activates Cdc25, which activates additional Cdc2-cyclin B complexes. Thus, a low level of CDK activity can be
amplified through this positive feedback loop, leading to
the concerted activation of Cdc2 and entry into mitosis.
To achieve an abrupt all-or-none activation of Cdc2 at the
right time, it is important that Cdc25 proteins not be activated at too low a level of Cdc2 activity. From this point
of view, one would predict that Cdc25 would be a poor
CDK substrate. A similar analysis applies to the activation
of Cdk2 complexes by Cdc25 proteins.

All three mammalian Cdc25 isoforms (A, B, and C) can be
phosphorylated on multiple sites by CDK-cyclin complexes (reviewed in [35-37]). Among 32 potential CDK
phosphorylation sites ((S/T)PXX) in human Cdc25A, B,
and C (Fig. 5A), only 2 sites fit the consensus CDK phosphorylation motif, and even these are weak fits for phosphorylation by Cdk2 (SPXR) since they lack a lysine at the
+3 position [24]. We conclude that most CDK phosphorylation of Cdc25 proteins occurs on non-canonical
motifs. We, therefore, examined whether Cdc25 proteins
could be phosphorylated by Cdk2-Speedy/Ringo A2. As
shown in Fig. 5B, both Cdk2-cyclin A and K2A2coexp phosphorylated GST-Cdc25A, B, and C. To compare the activities of Cdk2-cyclin A and Cdk2-Speedy/Ringo A2 toward
Cdc25, we varied the amounts of [pT160]Cdk2-cyclin A
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and K2A2coexp used to phosphorylate constant amounts of
GST-Cdc25A, B, and C. We estimated that the enzymatic
activity of [pT160]Cdk2-cyclin A toward the Cdc25
proteins was 7–14 fold higher than that of K2A2coexp. In
contrast, [pT160]Cdk2-cyclin A phosphorylated histone
H1 >1000-fold more efficiently than Cdk2-Speedy/Ringo
A2 (Fig. 5C).
To determine whether Cdk2-Speedy/Ringo A2 and Cdk2cyclin A phosphorylate Cdc25 proteins on the same or different sites, we compared tryptic phosphopeptide maps of
Cdc25 proteins phosphorylated by [pT160]Cdk2-cyclin A
(Fig. 6A) with those phosphorylated by K2A2coexp (Fig.
6B). Each Cdc25 protein was phosphorylated to about the
same extent by each Cdk2 complex. Since there are multiple potential CDK phosphorylation sites in Cdc25 proteins (Fig. 5A), it was not surprising that multiple sites
were actually phosphorylated. As shown in Fig. 6, phosphorylation of each Cdc25 protein by Cdk2-Speedy/
Ringo A2 and by Cdk2-cyclin A produced distinct phosphopeptide patterns. These phosphopeptides could be
grouped into two categories. First, many phosphopeptides
were unique for either Cdk2-cyclin A or Cdk2-Speedy/
Ringo A2, indicating a very strong influence of Cdk2 partner on phosphorylation specificity. For example, spots A1,
A2, B1, B2, and B3 were unique for Cdk2-cyclin A,
whereas spots a1, a2, b1, b2, and c4 were exclusively associated with Cdk2-Speedy/Ringo A2. Phosphopeptides in
the second group were phosphorylated by both kinases,
but to different extents. For example, in the phosphopeptide maps of Cdc25A, spots A3, A4, A5, and A6 generated
by Cdk2-cyclin A (Fig. 6A) appear to be identical to spots
a3, a4, a5, and a6 generated by Cdk2-Speedy/Ringo A2
(Fig. 6B), respectively. While Cdk2-cyclin A phosphorylated site A3 more strongly than sites A4, A5, and A6,
Cdk2-Speedy/Ringo A2 had the opposite site preference.
In the phosphopeptide maps of Cdc25C, Cdk2-cyclin A
phosphorylated peptide C2 more efficiently than peptide
C1 whereas Cdk2-Speedy/Ringo A2 phosphorylated C1
more efficiently than C2. Therefore, Cdk2-Speedy/Ringo
A2 and Cdk2-cyclin A have distinct but partially overlapping substrate preferences on natural substrates.
Cdk2 activation loop conformation in Cdk2-Speedy/Ringo
A2 complexes
We used accessibility to kinases and phosphatases to
probe the conformation of the Cdk2 activation loop in
Cdk2-Speedy/Ringo A2 complexes. The activation loop
plays an important role in substrate recognition by Cdk2cyclin A as the Thr-160 phosphate makes direct contact
with the +3 position of substrates. The strikingly different
substrate preferences of Cdk2-cyclin A and Cdk2-Speedy/
Ringo A2 raised the possibility that the activation loop in
Cdk2-Speedy/Ringo A2 might adopt a different conformation from that exhibited by Cdk2-cyclin A. In addition,
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Figure
Speedy/Ringo
Velocity4versusA2
concentration plots for phosphorylation of substrates by [unP]Cdk2-Speedy/Ringo A2 and [pT160]Cdk2Velocity versus concentration plots for phosphorylation of substrates by [unP]Cdk2-Speedy/Ringo A2 and
[pT160]Cdk2-Speedy/Ringo A2. Velocity versus concentration plots for [unP]Cdk2-Speedy/Ringo A2 (A) and
[pT160]Cdk2-Speedy/Ringo A2 (B). The substrates are histone H1 (solid circles), KSPRK (solid squares), KSPRR (open
squares), and KSPRY (open circles).
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Figure 5
Phosphorylation
of Cdc25A, B, and C by Cdk2-Speedy/Ringo A2
Phosphorylation of Cdc25A, B, and C by Cdk2-Speedy/Ringo A2. (A) Potential CDK phosphorylation sites in human
Cdc25A, B, and C. There are 12 (S/T)PXX sequences in Cdc25A, 14 in Cdc25B, and 6 in Cdc25C. The two sequences that
come closest to fitting the consensus CDK phosphorylation sequence (S/T)PX(K/R) are underlined. (B) Phosphorylation of
Cdc25A, B, and C by K2A2coexp and [pT160]Cdk2-cyclin A. Phosphorylation of GST-Cdc25A, B, and C (5 µg) by the indicated
amounts of K2A2coexp (lanes 1–6) or Cdk2-cyclin A (lanes 7–12). Phosphorylated proteins were separated by SDS-PAGE and
detected by autoradiography. (C) Phosphorylation of histone H1 by K2A2coexp and [pT160]Cdk2-cyclin A. Histone H1 (5 µM)
was phosphorylated by the indicated amounts of K2A2coexp (lanes 1–6) or Cdk2-cyclin A (lanes 7–12). Phosphorylated proteins
were separated by SDS-PAGE and detected by autoradiography.
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Figurephosphopeptide
Trypic
6
mapping of Cdc25 proteins
Trypic phosphopeptide mapping of Cdc25 proteins. Tryptic phosphopeptide mapping of Cdc25 phosphorylated by
[pT160]Cdk2-cyclin A (A) and by K2A2coexp (B). GST-Cdc25A, B, and C (5 µg) were phosphorylated by K2A2coexp and
[pT160]Cdk2-cyclin A, separated by 10% SDS-PAGE, extracted, and digested with trypsin. Phosphopeptides were separated on
thin layer chromatography plates by electrophoresis followed by chromatography and were detected by autoradiography.

Page 11 of 17
(page number not for citation purposes)

BMC Biochemistry 2005, 6:19

like Cdk2-Speedy/Ringo A2, monomeric [pT160]Cdk2
displayed low enzymatic activity toward histone H1
([29,33] and Fig. 1B) and defective substrate binding [29].
Structural studies indicate that the activation loop in
monomeric [pT160]Cdk2 is highly disorganized and that
only a very small population of [pT160]Cdk2 is in the
active conformation at any given time [33]. This comparison raised the possibility that the activation loop in
Cdk2-Speedy/Ringo A2 might also be disordered.
We first probed the T-loop conformation in Cdk2-Speedy/
Ringo A2 using budding yeast Cak1p. Cak1p phosphorylates monomeric Cdk2 efficiently, but this phosphorylation is inhibited over 95% in the presence of cyclin A [38],
presumably because the fixed conformation of the activation loop in Cdk2-cyclin A forms a poor substrate for
Cak1p. A kinase-inactive form of Cdk2 (GST-Cdk2D145N)
was used in this assay to eliminate the high background
phosphorylation of Speedy/Ringo A2 by wild-type Cdk2.
GST-Cdk2D145N bound in vitro translated [35S]-Speedy/
Ringo A2 as well as wild-type Cdk2 (data not shown).
GST-Cdk2 was preincubated with increasing amounts of
GST-Speedy/Ringo A2 or GST alone before phosphorylation by Cak1p. As shown in Fig. 7A, the phosphorylation
of Cdk2 by Cak1p was reduced in the presence of high
concentrations of Speedy/Ringo A2, indicating that the
binding of Speedy/Ringo A2 to Cdk2 changed the conformation of the activation loop.
We next investigated the T-loop conformation of Cdk2Speedy/Ringo A2 using mammalian CAK (Cdk7/cyclin H/
Mat1). Monomeric CDKs are poor substrates for mammalian CAK whereas the binding of cyclin stimulates activating phosphorylation by CAK more than seven fold [38].
We again used a kinase-inactive form of GST-Cdk2 (GSTCdk2D145N) to reduce background phosphorylation of
GST-Speedy/Ringo A2 by wild-type Cdk2. GST-Cdk2D145N
alone was slightly phosphorylated by CAK (Fig. 7B, lane
1). The phosphorylation of GST-Cdk2D145N was greatly
enhanced in the presence of cyclin A (Fig. 7B, lane 4). In
contrast, GST-Speedy/Ringo A2 had no effect on the phosphorylation GST-Cdk2D145N by CAK (Fig. 7B, lane 5). The
defective phosphorylation of Cdk2-Speedy/Ringo A2 by
mammalian CAK is unlikely to be due to a failure of
Speedy/Ringo A2 and GST-Cdk2D145N to form a complex.
Taking these results together, we conclude that binding of
Speedy/Ringo A2 alters the activation loop conformation
of Cdk2 (Fig. 7A), but in a manner distinct from how cyclin A does so (Fig. 7B). Furthermore, it appears that Cdk2Speedy/Ringo A2 is a poor substrate for mammalian CAK.
Finally, we examined the T-loop conformation in the
Cdk2-Speedy/Ringo A2 complex using serine/threonine
protein phosphatase type 2C (PP2C) [39]. Mammalian
PP2Cα and β can remove the activating phosphate from
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monomeric CDKs such as Cdk2 and Cdk6 [40]. The
binding of cyclin A to Cdk2 prevents dephosphorylation
by PP2C [40], presumably because the activation loop
becomes locked into a conformation inaccessible to PP2C
[41]. We tested whether Speedy/Ringo A2, like cyclin A,
can prevent dephosphorylation by PP2Cα. GSTCdk2D145N was labeled with [γ-32P]-ATP using Cak1p and
purified by gel filtration. 32P-labeled Cdk2 was preincubated with Speedy/Ringo A2, cyclin A, or buffer before
addition of PP2Cα. As described previously [40], cyclin A
fully blocked the dephosphorylation of Cdk2 (Fig. 7C,
compare lanes 3 and 4). The binding of Speedy/Ringo A2
partially blocked the dephosphorylation of Cdk2 by
PP2Cα (Fig. 7C, lane 8). Based on this intermediate result
we conclude, as with the Cak1p and CAK results above,
that binding to Speedy/Ringo A2 alters the conformation
of the activation loop, but that this conformation differs
from that seen after binding of cyclin A.

Discussion
The recently discovered Speedy/Ringo proteins represent a
novel class of non-cyclin CDK activators that play important roles in cell cycle progression. Xenopus Speedy/Ringo
is necessary for G2/M progression during oocyte maturation and a human Speedy/Ringo protein (Spy1) regulates
S-phase entry in cultured cells [25-28]. Although
apparently not present in yeast, plants, and insects,
Speedy/Ringo homologues can be found in the most
primitive branching clade of chordates (Ciona intestinalis)
[34], from which all vertebrates evolved. It is conceivable
that Speedy/Ringo proteins regulate cell cycle progression
in all vertebrates. Although there is no obvious primary
sequence similarity between cyclins and Speedy/Ringo
proteins, Speedy/Ringo proteins can bind to and activate
CDKs directly [27,34]. In this study, we carried out a
biochemical characterization of Cdk2-Speedy/Ringo A2
complexes. We verified that human Speedy/Ringo A2 can
form a 1:1 complex with Cdk2 and that it can activate
Cdk2 in vitro, even in the absence of phosphorylation of
Cdk2 on Thr-160.
However, Speedy/Ringo A2 is not a simple replacement
for certain cyclins; there are many important biochemical
differences between cyclins and Speedy/Ringo proteins.
First, Cdk2-Speedy/Ringo A2 displays a broad substrate
specificity, which is very different from the narrow consensus CDK phosphorylation motif. Previous studies
showed that Cdk2-cyclin A phosphorylated (K/R)(S/
T)PX(K/R) sequences, with a strong preference for a lysine
at the terminal position. We found, using a systematic
peptide substrate panel, that the +3 position is also the
most important residue for Cdk2-Speedy/Ringo A2 recognition. At the +3 position, the best substrates for Cdk2cyclin A are KSPRK and KSPRR (~5% of KSPRK), which
contain basic residues at the +3 position [24]. In contrast,
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Figureof7 Speedy/Ringo A2 binding on the phosphorylation and dephosphorylation of Cdk2 on Thr-160
Effects
Effects of Speedy/Ringo A2 binding on the phosphorylation and dephosphorylation of Cdk2 on Thr-160. (A)
Speedy/Ringo A2 hinders the phosphorylation of Cdk2 on Thr-160 by budding yeast Cak1p. GST-Cdk2D145N (1 µg) was incubated with increasing amounts (0, 1, 2.5, 5, and 10 µg) of GST-Speedy/Ringo A2 or GST prior to phosphorylation by Cak1p
(100 ng). The reactions were terminated and phosphorylated proteins were resolved by SDS-PAGE and detected by autoradiography. (B) Speedy/Ringo A2 binding did not stimulate Thr-160 phosphorylation by mammalian CAK. GST-Cdk2D145N (1 µg;
lanes 1, 4, 5) was preincubated with cyclin A (1 µg; lanes 2 and 4) or GST-Speedy/Ringo A2 (4 µg; lanes 3 and 5) before phosphorylation by CAK. Samples were processed as described in Methods. (C) Speedy/Ringo A2 hinders the dephosphorylation of
Cdk2 on Thr-160 by PP2Cα. [32P-T160]GST-Cdk2D145N was preincubated with cyclin A (lanes 2 and 4), GST-Speedy/Ringo A2
(lanes 6 and 8), or buffer alone (lanes 1, 3, 5, 7) prior to addition of recombinant human PP2Cα (lanes 3, 4, 7, 8) or buffer (lanes
1, 2, 5, 6). [32P-T160]GST-Cdk2D145N was detected by autoradiography.
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the best substrates for Cdk2-Speedy/Ringo A2 contained
tyrosine (Y), arginine (R), and tryptophan (W) in the +3
position, all of which carry bulky side chains. Furthermore, Cdk2-Speedy/Ringo A2 complexes could tolerate
almost any amino acid residue at the +3 position and
phosphorylated 17 of the 20 +3 substrates at least 50% as
well as KSPRK. More than half of the +3 substitutions
yielded substrates that were phosphorylated more efficiently than KSPRK. Only alanine, aspartate, and glutamate formed poor substrates, whose relative
phosphorylation by Cdk2-Speedy/Ringo A2 was still
higher than the relative phosphorylation of all but a few
of the +3 substrates by Cdk2-cyclin A.
The second difference between cyclins and Speedy/Ringo
A2 is that Cdk2-Speedy/Ringo A2 possesses low enzymatic activity toward conventional CDK substrates, indicating that Speedy/Ringo A2 is unlikely to be able to
replace cyclins and promote the full range of Cdk2
substrate phosphorylation. For example, the activity of
Cdk2-Speedy/Ringo A2 toward histone H1 was only
~0.1% the activity of [pT160]Cdk2-cyclin A in the standard histone H1 kinase assay. Therefore, it is unlikely that
CDK-Speedy/Ringo can promote cell cycle progression by
itself. The broad tolerance of Cdk2-Speedy/Ringo A2 for
substitutions at the +3 position of substrates and its low
activity toward conventional Cdk2 substrates may go
hand in hand. The insensitivity of Cdk2-Speedy/Ringo A2
to phosphorylation of Thr-160 on Cdk2 may also
contribute to its low activity toward conventional substrates as this phosphate plays a direct role in substrate
recognition via interaction with +3 basic residues. Indeed,
the activation loop conformation adopted by Cdk2 upon
binding Speedy/Ringo A2 appears to differ significantly
from that adopted upon cyclin A binding. Cdk2-Speedy/
Ringo A2 also appeared to bind substrates, except for
KSPRR, poorly, which may contribute to its low enzymatic
activity.
Although it displays a low enzymatic activity toward conventional CDK substrates such as histone H1, Cdk2Speedy/Ringo A2 actually phosphorylated non-canonical
CDK substrates nearly as well as Cdk2-cyclin A. We
extended this observation made using model substrates to
physiological CDK substrates, the Cdc25 dual-specificity
phosphatases. We found that Cdk2-Speedy/Ringo A2
could phosphorylate the three human Cdc25 proteins
quite efficiently, about 1000 times more efficiently than
would be expected based on the histone H1 kinase activity
of Cdk2-Speedy/Ringo A2 and only about an order of
magnitude less well than Cdk2-cyclin A. Furthermore,
phosphopeptide mapping of Cdc25 proteins confirmed
that the substrate specificity of Cdk2-Speedy/Ringo A2
overlaps with but is distinct from that of Cdk2-cyclin A. It
should also be pointed out that, in addition to inherent
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substrate specificity, some CDKs are targeted to some of
their substrates. For example, the S-phase cyclins, such as
cyclin A and Clb5, possess a 'hydrophobic patch' that can
interact with the 'RXL' or 'Cy' motif present in some substrates to carry out specific functions during DNA replication [18,31,42-46]. In contrast, phosphorylations of
histone H1 and GST-peptide substrates are independent
of any docking site. Thus, for Cdk2-Speedy/Ringo A2, the
existence of a docking site on Speedy/Ringo A2 would
greatly increase the phosphorylation of select substrates
by Cdk2-Speedy/Ringo A2.
A third difference between cyclins and Speedy/Ringo A2 is
that Speedy/Ringo A2 can activate Cdk2 independent of
the activating phosphorylation on Thr-160 of Cdk2. Previous studies have shown that Xenopus Speedy/Ringo can
activate Cdc2 and Cdk2 in vitro in the absence of activating phosphorylation and that it can render Cdk2 less sensitive to inhibition via inhibitory phosphorylation and
binding of CKIs such as p21 [27]. We examined whether
activating phosphorylation, though not necessary for
phosphorylation of histone H1, might nonetheless affect
the substrate specificity of Cdk2-Speedy/Ringo A2. Neither the overall catalytic activity of Cdk2-Speedy/Ringo A2
nor its substrate recognition required the activating phosphorylation of Cdk2. In fact, Thr-160 phosphorylation
reduced the activity of Cdk2-Speedy/Ringo A2 toward
most of the tested substrates and did not promote activity
toward any particular substrate. We also found that Cdk2Speedy/Ringo A2 is a poor substrate for metazoan CAK
(Cdk7/Cyclin H/Mat1). These findings indicate that the
activation of Cdk2 by Speedy/Ringo A2 does not require
the activating phosphorylation by CAK and that it may
proceed in the absence of this phosphorylation.

Conclusion
We have identified crucial biochemical differences
between Cdk2-cyclin A and Cdk2-Speedy/Ringo A2 complexes. These findings raise the possibility that Speedy/
Ringo A2 could play a significant role in the phosphorylation of CDK substrates containing non-canonical phosphorylation sites and suggest that Cdc25 proteins might
be physiological targets for Cdk2-Speedy/Ringo A2 complexes. This is an intriguing possibility given the positive
feedback that exists, for instance, between activation of
Cdc2 by Cdc25 and of Cdc25 by Cdc2. CDK-Speedy/
Ringo complexes – which do not require activating phosphorylation by CAK and are less sensitive to inhibitory
phosphorylation and CDK inhibitors such as p21 – would
be in a strong position to jump-start a positive feedback
loop or to reverse the inhibition of Cdc25 caused by
stresses such as that caused by DNA damage.
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Methods
Reagents
[γ-32P]-ATP (3000 Ci/mmol) was from Dupont-NEN
(Boston, MA). E. coli BL21-Codon plusRIL and BL21(DE3)Codon plusRIL cells were from Stratagene (La Jolla, CA).
Calf thymus histone H1 (Cat. #1004875) was from Roche
Diagnostics Inc (Indianapolis, IN). All other chemicals
were from Sigma (St. Louis, MO) unless indicated otherwise. 1 × protease inhibitor mix (PI) contained 1 mM
PMSF and 10 µg/ml each of leupeptin, chymostatin, and
pepstatin. EB buffer is 80 mM β-glycerophosphate, pH
7.3, 20 mM EGTA, 15 mM MgCl2, 10 mM DTT, 1 mg/ml
ovalbumin, and 1 × PI. Buffer A is 20 mM Tris-HCl, pH
7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 1 mg/ml
ovalbumin, 0.1% Tween 20, 1 × protease inhibitors. 1 ×
TBS buffer is 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5
mM EDTA, 0.5 mM DTT. Rabbit anti-Cdk2 antibodies
were from Santa Cruz Biotech (Santa Cruz, CA). HRP-conjugated secondary antibodies and SuperSignal™ ECL reagents were from Pierce (Rockford, IL).
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corresponding sites. The resulting K2A2coexp coexpression
vector was transformed into BL21(DE3)-Codon plusRIL
cells. K2A2coexp was induced using IPTG, partially purified
on a metal affinity column as described [39], and loaded
onto a Superdex-200 column pre-equilibrated with 1 ×
TBS buffer at a flow rate of 0.5 ml/min. Fractions containing Cdk2 were pooled and concentrated to about 2 mg/
ml. The concentration of Cdk2 was determined by immunoblotting using GST-Cdk2 as a standard. Cdk2-Speedy/
Ringo A2 complexes produced by coexpression in bacteria
are designated K2A2coexp and always contained Cdk2
unphosphorylated on Thr-160.
Cdk2-Speedy/Ringo A2 complexes were also formed in
vitro by mixing purified GST-Cdk2 with a three-fold molar
excess of GST-Speedy/Ringo A2 in 1 × EB at room temperature for 20 min. For some experiments, the Cdk2 was
first phosphorylated on Thr-160 by coexpression with
Cak1p in bacteria (see above). Cdk2-cyclin A complexes
were formed in vitro by mixing purified GST-[unP]Cdk2 or
GST-[pT160]Cdk2 with an equal molar amount of cyclin
A in 1 × EB at room temperature for 20 min.

Protein expression and purification
GST-Speedy/Ringo A2 [39], GST-Cdk2 [31], human
PP2Cα [40], GST-Cdk2 mutants [38,47], GST-Cak1p [14],
Cdk7/cyclin H [38], and GST fusion substrates [24] have
been described previously. The GST-Cdk2/GST-Cak1p
bicistron expression plasmid was constructed by Neil
Hanlon (University of Oxford, UK) and provided by Louise Johnson (University of Oxford, UK). GST[pT160]Cdk2 was expressed as described [31]. A plasmid
expressing a C-terminally his6-tagged version of the
portion of bovine cyclin A3 corresponding to residues
171–432 of human cyclin A was provided by John Lew
(University of California, Santa Barbara, CA) and purified
as described [48]. For simplicity, we refer to this protein as
cyclin A. Expression vectors for GST-Cdc25A, B, and C
were provided by Anindya Dutta (University of Virginia)
[49].

ATPase assays
To measure the rate of ATP hydrolysis by [pT160]Cdk2cyclin A and K2A2coexp, 16.7 µM of [pT160]Cdk2-cyclin A
or K2A2coexp in 10 µl of ATPase buffer (50 mM Tris-HCl,
pH 7.4, 15 mM MgCl2, 150 mM NaCl, 1 mg/ml ovalbumin, 10 mM DTT, 0.5% Tween-20, and 1 × protease
inhibitors) was mixed with an equal volume of ATP mix
containing 1 mM ATP and 0.5 µCi/µl [γ-32P]ATP in ATPase
buffer. At each time point, 1 µl of the assay was mixed
with 4 µl of Stop buffer (ATPase buffer containing 20 mM
EDTA instead of 15 mM MgCl2). 1 µl of the terminated
reaction was spotted onto a polyethyleneimine cellulose
plate (Selecto Scientific, Norcross, GA), and chromatographed for 2 h in 50 mM HCl. Plates were dried and
rechromatographed prior to PhosphorImager analysis.

To coexpress Cdk2-Speedy/Ringo A2-His6 in bacteria
(K2A2coexp), mouse Speedy/Ringo A2 was first amplified
by polymerase chain reaction using an N-terminal primer
to incorporate a HindIII site and a ribosome binding site
before the start codon, and a C-terminal primer to remove
the stop codon and add a XhoI site. The DNA sequences of
the PCR primers are as follows (cloning sites are underlined):
5'-CCCCAAGCTTAAGGAGGGATAGCCATGGGACGGCATAATCAGATGTATTG-3'
and
5'The
CCCCCTCGAGTTCTTCACTCTCTGCAAACC-3'.
resulting DNA was digested with the indicated restriction
enzymes and cloned into pET21d (Novagen) at the HindIII and XhoI sites, placing it in-frame with a C-terminal
polyhistidine (his6) tag in the vector. Finally, HA-tagged
Cdk2 was excised from an expression vector [12] using
NcoI and BamHI and cloned into pET21d at the

In vitro kinase assay and data analysis
Cdk2-Speedy/Ringo A2 mixtures were prepared as
described above. The Cdk2 concentration in the enzyme
mixture was adjusted to 0.1 µg/µl for GST-Cdk2 in GSTCdk2-Speedy/Ringo A2 complexes and to 0.055 µg/µl for
Cdk2 in K2A2coexp. To determine the substrate specificity
and enzymatic activity of Cdk2-Speedy/Ringo A2 (Figs. 2,
3), kinase assays were carried out by incubating 5 µl of
enzymes (8.6 pmol of Cdk2) with 5 µl of substrates (13 µg
GST substrates or 1.3 µg histone H1) in the presence of
0.25 µCi/µl [γ-32P]-ATP, and 0.4 mM ATP in 1 × EB at
25°C. Reactions proceeded for 10 min and were terminated by addition of 5 µl of 3 × SDS-PAGE sample buffer.
Samples were resolved by 10% SDS-PAGE and analyzed
by autoradiography and phosphorimaging. Substrate
bands were also excised and quantified by liquid scintilla-
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tion counting. To determine the phosphorylation efficiency-concentration plot (Fig. 4), 5 µl of enzymes (8.6
pmol) were incubated with 5 µl of substrates in the presence of 0.25 µCi/µl [γ-32P]-ATP, and 1 mM ATP in 1 × EB
for 10 min at 25°C. The reaction was terminated by the
addition of 5 µl of 3 × SDS-PAGE sample buffer. Samples
containing more than 10 µg of GST substrates or 1 µg of
histone H1 were diluted in 1 × sample buffer before SDSPAGE. Samples were resolved by 10% SDS-PAGE and analyzed by autoradiography and phosphorimaging. Individual substrate bands were excised and quantified by liquid
scintillation counting. Data were analyzed using the MSexcel program.
Phosphorylation of GST-Cdc25A, B, C, and histone H1
For the comparative analysis of Cdc25 and histone H1
phosphorylation by Cdk2-Speedy/Ringo A2 and
[pT160]Cdk2-cyclin A (Fig. 5), 5 µl of substrate (5 µg of
GST-Cdc25 or 5 µM of histone H1 in EB) was mixed with
5 µl of enzyme mix containing the indicated amounts of
coexpressed Cdk2-Speedy/Ringo A2 or of [pT160]Cdk2cyclin A in the presence of 0.25 µCi/µl [γ-32P]-ATP, 0.4
mM ATP in 1 × EB. The reactions proceeded for 10 min at
room temperature and were terminated by addition of 5
µl of 3 × SDS-PAGE sample buffer. Samples were resolved
by 10% SDS-PAGE and analyzed by autoradiography and
phosphorimaging.
Tryptic phosphopeptide mapping of Cdc25 proteins
GST-Cdc25A, B, and C (5 µg) were phosphorylated in the
presence of [γ-32P]-ATP by coexpressed Cdk2-Speedy/
Ringo A2 or [pT160]Cdk2-cyclin A as described above.
[32P]-Cdc25 was subjected to tryptic peptide mapping as
described [50]. Briefly, samples were resolved by 10%
SDS-PAGE, excised from gels, and extracted in 50 mM
ammonium bicarbonate, 10% β-mercaptoethanol, and
0.2% SDS. Cdc25 was precipitated with cold trichloroacetic acid (20%) in the presence of 20 µg of bovine serum
albumin as a carrier. The precipitated pellets were washed
twice with ice cold acetone. Cdc25 proteins were then
digested with 20 µg of sequencing grade trypsin
(Promega, Cat#V5111) at 37°C overnight. The tryptic
peptides were separated on thin-layer cellulose plates (EM
chemicals) by horizontal electrophoresis at 1,000 V for 25
min in pH 1.9 buffer (2.5% [vol/vol] formic acid and
7.8% [vol/vol] acetic acid) followed by ascending thinlayer chromatography in 32.5% [vol/vol] n-butanol, 25%
[vol/vol] pyridine, 7.5% [vol/vol] acetic acid. Following
chromatography,
the
plate
was
dried
and
autoradiographed.
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temperature for 20 min. Phosphorylation of Cdk2 on the
activating phosphorylation site by yeast Cak1p and mammalian CAK was carried out as described [38]. The reaction was terminated by the addition of 3 × SDS-PAGE
sample buffer. Samples were resolved in 10% SDS-PAGE
and analyzed by autoradiography.
32P-labeled

GST-Cdk2D145N was prepared and purified as
described previously [39]. The dephosphorylation of 32PCdk2 by PP2C were carried out as described [39,40].
Briefly, ~80 ng of 32P-Cdk2 was incubated with an excess
of cyclin A (0.5 µg), GST-Speedy/Ringo A2 (1 µg), or
buffer A at room temperature for 20 min. Samples were
incubated at room temperature for 10 min following the
addition of 100 ng of recombinant human PP2Cα [40].
Samples were analyzed by 10% SDS-PAGE as described
above.

List of abbreviations
CAK, Cdk-Activating Kinase; CDK, cyclin-dependent protein kinase; Spy1, Speedy; GST, glutathione S-transferase;
PAGE, polyacrylamide gel electrophoresis.
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